DarcyG
The official ACBS list of ACT randomized controlled trials has now passed 1,500! This milestone offers a fascinating look at how ACT research has grown, where the work is happening, and how the field is changing.
There’s more to the story than a big number. Nearly half of ACT RCTs have come from Lower and Middle Income Countries. ACT research is increasingly appearing in high-impact journals, and more than 119,000 people have participated in ACT RCTs worldwide.
So, what does 1,500 trials actually tell us about the evolution—and future—of ACT and CBS? Read the article written about the milestone written by Steven Hayes here!